About OmicEra Diagnostics
OmicEra Diagnostics is a company based in Munchen (Germany) founded in 2019 was acquired by Exact Sciences in May 2022.. The company has 9 employees as of December 31, 2021. OmicEra Diagnostics operates in a competitive market with competitors including Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others.
- Headquarter Munchen, Germany
- Employees 9 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Omicera Diagnostics Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
9
as on Dec 31, 2021
-
Acquired by
Exact Sciences
(May 10, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of OmicEra Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OmicEra Diagnostics
OmicEra Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Exact Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Non-invasive molecular diagnostic tests for cancer detection are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OmicEra Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OmicEra Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Omicera Diagnostics Comparisons
Competitors of OmicEra Diagnostics
OmicEra Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based protein-modeling software is developed for drug discovery.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| domain | founded_year | HQ Location |
Proteomics services are delivered via discovery and targeted platforms.
|
|
| domain | founded_year | HQ Location |
Provider tools to help researchers with protein analysis
|
|
| domain | founded_year | HQ Location |
Small molecule oncology therapeutics are developed for cancer treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Omicera Diagnostics
Frequently Asked Questions about OmicEra Diagnostics
When was OmicEra Diagnostics founded?
OmicEra Diagnostics was founded in 2019.
Where is OmicEra Diagnostics located?
OmicEra Diagnostics is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
How many employees does OmicEra Diagnostics have?
As of Dec 31, 2021, the latest employee count at OmicEra Diagnostics is 9.
What does OmicEra Diagnostics do?
OmicEra Diagnostics was established in 2019 in Munich, Germany. Focus is placed on the biotechnology sector, specifically diagnostics through proteomic tools. Software and platforms for analyzing protein data are developed and offered to support research and clinical applications. Operations center on enabling efficient data processing in life sciences. The company addresses needs in omics-based workflows across European markets.
Who are the top competitors of OmicEra Diagnostics?
OmicEra Diagnostics's top competitors include Vividion Therapeutics, Cyrus Biotechnology and Biognosys.
Who are OmicEra Diagnostics's investors?
OmicEra Diagnostics has 1 investor. Key investors include Exact Sciences.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.